Find your next paid study

Leading Edge ClinicNCT07567274

~$75 – $2,000

Actual pay is set by the research site.

A Veteran-Centered Medically Tailored Meal Intervention to Improve Clinical and Patient Reported Outcomes in Chronic Kidney Disease (VETCKD)

This study will study if medically tailored meals can improve health and well-being among Veterans with kidney disease. Participants will be randomly assigned …

Chronic Kidney Disease

VA Office of Research and DevelopmentNCT07793591

~$10 – $675

Actual pay is set by the research site.

Peripheral Artery DiseasePeripheral Artery StenosisPeripheral Artery Calcification+1 more

The THOR IDE Study

The goal of this clinical trial is to test the Thor system in adult (≥ 18 year old) patients with de novo (new, never treated) calcified lesions in infrainguin…

Philips Clinical & Medical Affairs GlobalNCT05916950

Actual pay is set by the research site.

Phase 4

Endotype DIrected Treatment for OSA in Down Syndrome

Down syndrome is the most common genetic cause of intellectual disability. People with Down syndrome often have obstructive sleep apnea (OSA), a condition wher…

Obstructive Sleep Apnea (OSA)Down Syndrome

University of ArizonaNCT07280468

~$25 – $1,000

Actual pay is set by the research site.

Patient-Centered Video Education Intervention to Improve Rural Cancer Care Delivery in Vermont: A Feasibility Study

Care Coordination is an essential component of cancer care delivery. Many patients experience poor care coordination. In this study, we hypothesize that provis…

Cancer

University of Vermont Medical CenterNCT05723250

Actual pay is set by the research site.

Phase 3

Randomized, Ph3 Clinical Study Comparing Vusolimogene Oderparepvec in Combination With Nivolumab Vs Treatment of Physician's Choice in Patients With Advanced Melanoma That Progressed on Anti-PD-1 and Anti-CTLA-4 Containing Treatment [IGNYTE-3]

This is a randomized, controlled, multicenter, open-label Phase 3 clinical study comparing VO in combination with nivolumab versus Physician's Choice treatment…

Advanced Melanoma

Replimune, Inc.NCT06264180

~$50 – $2,100

Actual pay is set by the research site.

The Gut-Brain Axis During Neurorehabilitation; Prebiotic Treatment to Alter the Gut Microbiome and Neurologic Symptoms

The aim of this study is to characterize the microbiome of patients undergoing post-acute residential neurorehabilitation compared to community controls and to…

Brain Injuries

The University of Texas Medical Branch, GalvestonNCT06607523

Actual pay is set by the research site.

Developmental Language DisorderLanguage Impairment

Emergent Bilinguals: the Relationship Between Child Language Proficiency and Language of Treatment on the Outcomes Children with Developmental Language Disorder

Of the 12 million children in the USA growing up bilingual, about 1 million experience Developmental Language Disorder (DLD), a disorder in language learning a…

University of HoustonNCT06866223

Actual pay is set by the research site.

Phase 1

A Phase I/Ib Global, Multicenter, Open-label Umbrella Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

This open-label, exploratory study is designed to evaluate the safety and efficacy of targeted therapies or immunotherapy as single agents or combinations, in …

Metastatic Colorectal Cancer

Hoffmann-La RocheNCT04929223

~$150 – $4,500

Actual pay is set by the research site.

Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma Patients

This study explores the relationship between pre-treatment dietary patterns, fecal microbiome, and response to chemotherapy in patients with pancreatic ductal …

Borderline Resectable Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal AdenocarcinomaStage I Pancreatic Cancer AJCC v8

Emory UniversityNCT06595160

Actual pay is set by the research site.

Improving Measurement and Treatment of Post-stroke Neglect

This study examines how to best assess and treat post-stroke neglect. This study will examine the preliminary effects of an innovative intervention (repetitive…

Stroke

VA Office of Research and DevelopmentNCT03317860

~$10 – $675

Actual pay is set by the research site.

Phase 2

A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.

Atopic DermatitisAtopicDermatitis+5 more